Cherokee it's certainly not a bad post but the thing is right now the company is valued at $50M with expenditure greater than revenue it's not a case of big pharma don't know AVH exists or the technology held by the company - stand by the same points a rise in value will only come from rising revenues unless somebody sees a greater value & moves to aquire the company. If you think it is worth more than $300M when the current price dictated by market is $50M then you are free to move forward & buy the entire company at a huge premium if you don't have the funds to do so then there's not really a place to argue it's worth more than $300M when it's currently 600% below that figure. If it was worth more it would be there - simple.
AVH Price at posting:
23.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)